Qimeng Chang

678 total citations
22 papers, 465 citations indexed

About

Qimeng Chang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Qimeng Chang has authored 22 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Qimeng Chang's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (4 papers). Qimeng Chang is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Ferroptosis and cancer prognosis (4 papers). Qimeng Chang collaborates with scholars based in China, United States and Ethiopia. Qimeng Chang's co-authors include Xubo Wu, Jianfa Wang, Zhiqiu Hu, Jin-Feng Feng, Ziping Zhang, Ziping Zhang, Yanfang Li, Jie Liu, Yaqiong Zhang and Liangli Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Frontiers in Microbiology.

In The Last Decade

Qimeng Chang

21 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qimeng Chang China 11 305 175 71 59 58 22 465
Hongping Wang China 13 251 0.8× 106 0.6× 51 0.7× 62 1.1× 26 0.4× 43 517
Tae Young Ryu South Korea 8 385 1.3× 137 0.8× 130 1.8× 49 0.8× 45 0.8× 14 542
Yuan Liang China 13 281 0.9× 104 0.6× 65 0.9× 26 0.4× 34 0.6× 22 539
Honglei Jiang China 12 254 0.8× 117 0.7× 82 1.2× 87 1.5× 20 0.3× 27 522
Kishor Pant United States 13 333 1.1× 91 0.5× 63 0.9× 79 1.3× 73 1.3× 25 568
Lulu He China 15 362 1.2× 189 1.1× 47 0.7× 42 0.7× 35 0.6× 37 640
Pan Xi China 8 287 0.9× 163 0.9× 39 0.5× 59 1.0× 21 0.4× 11 450
Zhen Ni China 13 288 0.9× 101 0.6× 70 1.0× 180 3.1× 44 0.8× 27 624
Ling Mao China 12 372 1.2× 309 1.8× 69 1.0× 72 1.2× 16 0.3× 25 600
Chu-Tian Mai China 11 354 1.2× 74 0.4× 49 0.7× 52 0.9× 23 0.4× 15 628

Countries citing papers authored by Qimeng Chang

Since Specialization
Citations

This map shows the geographic impact of Qimeng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qimeng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qimeng Chang more than expected).

Fields of papers citing papers by Qimeng Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qimeng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qimeng Chang. The network helps show where Qimeng Chang may publish in the future.

Co-authorship network of co-authors of Qimeng Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Qimeng Chang. A scholar is included among the top collaborators of Qimeng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qimeng Chang. Qimeng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Wei‐Guo, Jin-Feng Feng, Xian Li, et al.. (2025). MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathway. Annals of Hepatology. 30(1). 101785–101785.
2.
Li, Yixin, Ji Xiong, Zhiqiu Hu, et al.. (2025). Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and sorafenib response in HCC. BMC Medicine. 23(1). 162–162. 3 indexed citations
3.
Chang, Qimeng, et al.. (2025). Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody. Biochemical Pharmacology. 237. 116927–116927. 3 indexed citations
4.
Chang, Qimeng, Xiang Zhou, Jin-Feng Feng, et al.. (2024). <i>ALKBH5</i> promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating <i>TTI1</i> expression. SHILAP Revista de lepidopterología. 24(5). 1216–1230. 2 indexed citations
5.
Xu, Yayun, Jianfa Wang, Xubo Wu, et al.. (2023). Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin. Gut Microbes. 15(1). 2168101–2168101. 26 indexed citations
6.
Xu, Yayun, Hui Jing, Jianfa Wang, et al.. (2022). Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea. Frontiers in Microbiology. 13. 800604–800604. 31 indexed citations
7.
Chang, Qimeng, Yayun Xu, Jianfa Wang, et al.. (2022). Effect of aging on acute pancreatitis through gut microbiota. Frontiers in Microbiology. 13. 897992–897992. 8 indexed citations
8.
Chang, Qimeng, et al.. (2022). Synthesis of CoFe2O4/MoO2 dumbbell-shaped nanoparticles with enhanced AMF/NIR induced drug delivery for liver cancer treatment. Ceramics International. 48(19). 28640–28648. 5 indexed citations
9.
Chang, Qimeng, Yayun Xu, Jianfa Wang, et al.. (2021). SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine. 2021. 1–9. 5 indexed citations
10.
Wang, Jianfa, et al.. (2021). RORγt inhibitor SR1001 alleviates acute pancreatitis by suppressing pancreatic IL‐17‐producing Th17 and γδ‐T cells in mice with ceruletide‐induced pancreatitis. Basic & Clinical Pharmacology & Toxicology. 129(5). 357–368. 6 indexed citations
11.
Zhang, Juxiang, Qimeng Chang, Xubo Wu, et al.. (2020). Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 39(1). 8 indexed citations
12.
Teng, Fei, Juxiang Zhang, Qimeng Chang, et al.. (2020). LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 39(1). 235–235. 97 indexed citations
13.
Hu, Zhiqiu, Ziping Zhang, Fei Teng, et al.. (2020). Role of Asxl2 in non‑alcoholic steatohepatitis‑related hepatocellular carcinoma developed from diabetes. International Journal of Molecular Medicine. 47(1). 101–112. 7 indexed citations
14.
Liu, Jiazhe, Hongcheng Wang, Jianfa Wang, et al.. (2019). Total flavonoid aglycones extract in Radix Scutellariae induces cross-regulation between autophagy and apoptosis in pancreatic cancer cells. Journal of Ethnopharmacology. 235. 133–140. 30 indexed citations
15.
Wu, Xubo, Xia Feng, Qimeng Chang, et al.. (2019). Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice. Journal of Experimental & Clinical Cancer Research. 38(1). 107–107. 30 indexed citations
16.
Wang, Jianfa, et al.. (2018). The association between preoperative serum interleukin‐6 levels and postoperative prognosis in patients with T2 gallbladder cancer. Journal of Surgical Oncology. 117(8). 1672–1678. 10 indexed citations
17.
Hu, Zhiqiu, Qimeng Chang, Yuhua Zhang, et al.. (2017). Effect of talin1 on apoptosis in hepatoma carcinoma cells via the PI3K/Akt/NF-κB signaling pathway. RSC Advances. 7(64). 40179–40188. 5 indexed citations
18.
Li, Yanfang, Puyu Yang, Qimeng Chang, et al.. (2017). Inhibitory Effect of Piceatannol on TNF-α-Mediated Inflammation and Insulin Resistance in 3T3-L1 Adipocytes. Journal of Agricultural and Food Chemistry. 65(23). 4634–4641. 39 indexed citations
19.
Shi, Da, et al.. (2017). A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma. Oncotarget. 8(35). 58699–58708. 30 indexed citations
20.
Yang, Mengxuan, Yingying Qu, Xubo Wu, et al.. (2016). Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer. Oncology Reports. 36(2). 779–786. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongping Wang Breakdown of academic impact, for papers by Tae Young Ryu Breakdown of academic impact, for papers by Yuan Liang Breakdown of academic impact, for papers by Honglei Jiang Breakdown of academic impact, for papers by Kishor Pant Breakdown of academic impact, for papers by Lulu He Breakdown of academic impact, for papers by Pan Xi Breakdown of academic impact, for papers by Zhen Ni Breakdown of academic impact, for papers by Ling Mao Breakdown of academic impact, for papers by Chu-Tian Mai
Rankless by CCL
2026